Matthew Perrone, WOKV News

Matthew Perrone

WOKV News

Washington, DC, United States

Contact Matthew

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • WOKV News

Recent articles by Matthew:

FDA head: Baby formula factory could reopen by next week

The Food and Drug Administration's commissioner says a shuttered baby formula factory could be up and running by next week → Read More

Lawmakers grill FDA commissioner over baby formula shortage

The Food and Drug Administration's commissioner is facing congressional lawmakers for the first time over the national shortage of baby formula → Read More

Baby formula shortage leads to congressional scrutiny of FDA

The head of the Food and Drug Administration is facing congressional lawmakers for the first time over the national shortage of baby formula → Read More

EXPLAINER: What we know about shuttered baby formula plant

Many questions remain about the shuttered Abbott baby formula plant at the center of a nationwide shortage → Read More

EXPLAINER: What's behind the baby formula shortage?

Many parents are hunting for infant formula after a combination of short- and long-term problems hit the biggest U.S. brands → Read More

Parents hunting for baby formula as shortage spans US

Parents across the U.S. are scrambling to find baby formula because of supply disruptions and a massive safety recall by manufacturer Abbott → Read More

Rare cases of COVID returning pose questions for Pfizer pill

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort → Read More

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots → Read More

FDA issues plan to ban menthol in cigarettes, cigars

The U.S. government has released its long-awaited plan to ban menthol cigarettes and flavored cigars → Read More

Lawmakers scrutinize McKinsey's opioid, FDA consulting work

Lawmakers vowed to continue investigating consulting firm McKinsey after a hearing scrutinizing its work for the Food and Drug Administration even as it advised opioid makers on boosting sales → Read More

Lawmakers scrutinize McKinsey's opioid, FDA consulting work

Lawmakers vowed to continue investigating consulting firm McKinsey’s company after a hearing scrutinizing the company's for the Food and Drug Administration even as it advised opioid drugmakers on boosting sales → Read More

McKinsey exec faces questions on opioid, FDA consulting work

A top McKinsey executive is set to answer congressional questions about his company’s consulting work for the Food and Drug Administration even as it advised opioid drugmakers on boosting sales → Read More

E-cigs using synthetic nicotine come under FDA oversight

The Food and Drug Administration says it will begin cracking down on e-cigarettes that have used synthetic nicotine to skirt oversight → Read More

US experts wrestle with how to update COVID-19 vaccines

Vaccine experts are grappling with how to formulate a U.S. strategy for future COVID-19 booster campaigns → Read More

US experts discuss COVID boosters for the fall and beyond

Vaccine experts are meeting to discuss the U.S. strategy for future COVID-19 booster campaigns → Read More

US pulls GSK's COVID drug as omicron sibling dominates cases

U.S. regulators say GlaxoSmithKline’s COVID-19 antibody drug should no longer be used because it is likely ineffective against the latest version of the virus that accounts for most cases → Read More

FDA panel narrowly sides against experimental ALS drug

U.S. health advisers have narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease → Read More

US opens second COVID boosters to 50 and up, others at risk

Americans age 50 and older can get a second COVID-19 booster if it’s been at least four months since their last vaccination → Read More

FDA OKs another Pfizer, Moderna COVID booster for 50 and up

U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine → Read More

FDA skeptical of benefits from experimental ALS drug

The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease → Read More